Details of the Drug Reposition

General Information of This Drug (ID: DM6K3JQ)

Drug Name
COTI-2   DM6K3JQ
Synonyms Coti-2; UNII-2BTA1O65BR; 2BTA1O65BR; 1039455-84-9; ZINC114475331; CS-8156; HY-19896; 1-Piperazinecarbothioic acid, 4-(2-pyridinyl)-, 2-(6,7-dihydro-8(5H)-quinolinylidene)hydrazide
Structure
3D MOL 2D MOL

Information on Drug Reposition of This Drug

Molecular Interaction Atlas (MIA)
6 Phase 1 Indication(s)
Indication Name Indication ID ICD-11 Status REF
Peritoneal cavity cancer DISBT2JS 2C51.Z Phase 1 [1]
Ovarian cancer DISZJHAP 2C73 Phase 1 [1]
Fallopian tube cancer DISXHWCS 2C74 Phase 1 [1]
Endometrial cancer DISW0LMR 2C76 Phase 1 [1]
Cervical cancer DISFSHPF 2C77.0 Phase 1 [1]
Head and neck cancer DISBPSQZ 2D42 Phase 1 [1]
------------------------------------------------------------------------------------
⏷ Show the Full List of 6 Indications(s)

References

1 Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)